Boulder Ventures

Array BioPharma focuses on developing targeted therapies for cancer and other diseases, emphasizing innovative drug discovery and development processes.

NeXstar Pharmaceuticals is a company specializing in pharmaceutical products.

Dharmacon offers a range of reagents for functional genomics, specializing in RNAi and CRISPR technologies.

Genomica is a pioneer in molecular diagnostics and genetic identification, specializing in in-vitro diagnostics and automated solutions that adhere to high scientific and regulatory standards.

Miragen Therapeutics focuses on developing treatments for autoimmune diseases, known for its work in antibody discovery.

ArcherDX provides software and databases for genomic analysis, particularly focusing on gene fusion data relevant to cancer research.

Mineralys specializes in selling collectible minerals, fossils, and artisanal jewelry made from natural stones. The company operates an online store with a wide selection of semi-precious stones and handcrafted jewelry.

Stardog is a Semantic AI Platform that enables organizations to connect, integrate, and analyze data across various sources, leveraging knowledge graphs and AI technologies.

Antithesis tests complex distributed systems. It automates end-to-end system testing and finds the unknown unknowns that traditional testing methods miss.

Synaptic helps healthcare, government, and technology organizations leverage AI to compete in today's marketplace. We provide vertical AI solutions that extend Salesforce environments with purpose-built apps and AI agents.

Travel Curious offers authentic private tours led by handpicked guides, providing bespoke local experiences and avoiding crowds.

Early-stage investor focused on Black, Latinx, and Indigenous founders, offering hands-on support in product, tech-stack strategy, and team structure.

Originating from a quantitative hedge fund, Two Sigma Ventures uses quant models and embeds data scientists, engineers, and researchers to tackle ML and data-pipeline challenges for AI, software infrastructure, and hardtech. The fund uses quantitative models and data science to support investment decisions and focuses specifically on companies that exploit the compounding of data and computing power, particularly in AI/ML, advanced software infrastructure, and hardtech at the intersection of climate, manufacturing, and life sciences.

Presight Capital is the international venture fund of entrepreneur Christian Angermayer, operating as a registered investment adviser that can invest across public and private markets with checks from $500K to $100M+ throughout a company's entire lifecycle from seed to post-IPO. The fund is backed by prominent hedge fund managers and billionaire angels rather than traditional institutional investors, and focuses heavily on controversial frontier science like psychedelics, brain-computer interfaces, and life extension alongside transformative infrastructure bets in undercapitalized global markets.